Bank Julius Baer & Co. Ltd, Zurich Compass Pathways PLC Transaction History

Bank Julius Baer & Co. Ltd, Zurich

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$11.13 - $23.04 $1,558 - $3,225	-140 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$21.81 - $48.96 $55,070 - $123,624	-2,525 Reduced 94.75%	140 $3,000
Q3 2021 Nov 12, 2021	BUY	$29.03 - $38.62 $14,979 - $19,927	516 Added 24.01%	2,665 $80,000
Q2 2021 Jul 23, 2021	SELL	$32.29 - $39.68 $32 - $39	-1 Reduced 0.05%	2,149 $82,000
Q1 2021 May 10, 2021	BUY	$34.75 - $57.5 $73,253 - $121,210	2,108 Added 5019.05%	2,150 $79,000
Q4 2020 Feb 24, 2021	BUY	$32.0 - $59.2 $64 - $118	2 Added 5.0%	42 $2,000
Q4 2020 Feb 12, 2021	SELL	$32.0 - $59.2 $62,720 - $116,032	-1,960 Reduced 98.0%	40 $2,000
Q3 2020 Nov 10, 2020	BUY	$28.83 - $43.17 $57,660 - $86,340	2,000 New	2,000 $70,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.